Skip to main content
. 2023 Apr 17;43(11):1357–1366. doi: 10.1093/asj/sjad100

Figure 4.

Figure 4.

Participant-assessed FACE-Q appraisal of lower eyelids at baseline and following VYC-15L treatment. Data from baseline and Months 1 to 12 are from the VYC-15L initial treatment population, and data from the 1-month posttreatment repeat are from the VYC-15L repeat treatment population.